PRESS RELEASE published on 01/30/2024 at 16:04, 2 years 3 months ago VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial VenoStent enrolls its first patient into a 200-subject, one-to-one randomized controlled trial (RCT) to improve outcomes from arteriovenous fistula creation surgery, as part of its SAVE-FistulaS Clinical Trial in the US. This trial marks a significant milestone in the development of bioabsorbable wraps for hemodialysis patients VenoStent SAVE-FistulaS Clinical Trial Arteriovenous Fistula Bioabsorbable Wrap Hemodialysis Patients
PRESS RELEASE published on 07/31/2023 at 16:04, 2 years 9 months ago VenoStent Completes $16M Series A Financing, Receives IDE Approval from FDA to Begin US Trial
Published on 05/11/2026 at 09:05, 2 hours 36 minutes ago Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Published on 05/11/2026 at 08:05, 3 hours 36 minutes ago Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/09/2026 at 01:30, 2 days 10 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/11/2026 at 11:36, 4 minutes ago LION Smart and LEAPENERGY secure the performance of their storage containers through multiple guarantees
Published on 05/11/2026 at 11:17, 24 minutes ago Aroundtown SA: Release of a capital market information
Published on 05/11/2026 at 11:10, 30 minutes ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
Published on 05/11/2026 at 11:09, 31 minutes ago Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Published on 05/11/2026 at 10:48, 53 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Published on 05/07/2026 at 19:15, 3 days 16 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 3 days 16 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 3 days 17 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
